Loss of pharyngeal muscle tone during sleep leads to recurrent airway obstruction. Preventing this collapse restores normal ventilation and prevents systemic hypoxia.

Diastolic dysfunction in heart failure with preserved ejection fraction prevents proper ventricular filling. Addressing this mechanical failure improves cardiac output and reduces pulmonary congestion.

Inconsistent solubility and thermodynamic instability of crystalline structures limit therapeutic efficacy. Improving these physical properties ensures predictable systemic absorption and potency.

Inadequate resolution of thrombi and high risk of secondary embolic events. Preventing these events reduces permanent neurological deficit and mortality.

Accumulation of pathological tau isoforms leads to irreversible neuronal dysfunction and cell death. Mitigating this proteotoxicity prevents cognitive decline in tauopathy patients.